Evidence map›Paper›PMID 26597988›Full record

ArticleInfection and immunity2016

The GraS Sensor in Staphylococcus aureus Mediates Resistance to Host Defense Peptides Differing in Mechanisms of Action.

Siyang Chaili, Ambrose L Cheung, Arnold S Bayer, Yan Q Xiong, Alan J Waring, Guido Memmi, Niles Donegan, Soo-Jin Yang, Michael R Yeaman

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Siyang ChailiDivision of Molecular Medicine, Los Angeles County Harbor-UCLA Medical Center, Torrance, California, USA Division of Infectious Diseases, Los Angeles County Harbor-UCLA Medical Center, Torrance, California, USA Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA.
Ambrose L CheungDepartment of Microbiology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
Arnold S BayerDivision of Infectious Diseases, Los Angeles County Harbor-UCLA Medical Center, Torrance, California, USA Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA The David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Yan Q XiongDivision of Infectious Diseases, Los Angeles County Harbor-UCLA Medical Center, Torrance, California, USA Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA The David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Alan J WaringDivision of Molecular Medicine, Los Angeles County Harbor-UCLA Medical Center, Torrance, California, USA Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA The David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Guido MemmiDepartment of Microbiology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
Niles DoneganDepartment of Microbiology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
Soo-Jin YangSchool of Bioresources and Bioscience, Chung-Ang University, Anseong, Republic of Korea.
Michael R YeamanDivision of Molecular Medicine, Los Angeles County Harbor-UCLA Medical Center, Torrance, California, USA Division of Infectious Diseases, Los Angeles County Harbor-UCLA Medical Center, Torrance, California, USA Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA The David Geffen School of Medicine at UCLA, Los Angeles, California, USA MRYeaman@ucla.edu.
Dartmouth College · USUCLA Medical Center · USChung-Ang University · KRHarbor–UCLA Medical Center · USThe Lundquist Institute · US

Funding

Staphylococcal Adaptations to Platelet Microbicidal ProteinR01AI039108 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI BAYER, ARNOLD S · 1997 to 2016
$5.1M
The role of GraRS in resistance to cationic antimicrobial peptides in S. aureusR01AI091801 · NIAID · DARTMOUTH COLLEGE · PI CHEUNG, AMBROSE LIN YAU · 2011 to 2015
$2.4M
The role of CshA and CshB in selective mRNA protection in S. aureusR01AI106937 · NIAID · DARTMOUTH COLLEGE · PI CHEUNG, AMBROSE LIN YAU · 2013 to 2016
$1.6M
Mitigating Resistance & Virulence in MRSAR33AI111661 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI YEAMAN, MICHAEL R · 2016 to 2018
$1.2M
Mitigating Resistance & Virulence in MRSAR21AI111661 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI YEAMAN, MICHAEL R · 2014 to 2015
$378k
NIAID NIH HHS 1 R21/R33-AI-111661-01NIAID NIH HHS 2 R01-AI091801-06NIAID NIH HHS 5 R01-AI-039108-17NIAID NIH HHS R01 AI039108NIAID NIH HHS R01 AI091801NIAID NIH HHS R01 AI106937NIAID NIH HHS R21 AI111661NIAID NIH HHS R33 AI111661
6 · The paper itself

Abstract

Staphylococcus aureus uses the two-component regulatory system GraRS to sense and respond to host defense peptides (HDPs). However, the mechanistic impact of GraS or its extracellular sensing loop (EL) on HDP resistance is essentially unexplored. Strains with null mutations in the GraS holoprotein (ΔgraS) or its EL (ΔEL) were compared for mechanisms of resistance to HDPs of relevant immune sources: neutrophil α-defensin (human neutrophil peptide 1 [hNP-1]), cutaneous β-defensin (human β-defensin 2 [hBD-2]), or the platelet kinocidin congener RP-1. Actions studied by flow cytometry included energetics (ENR); membrane permeabilization (PRM); annexin V binding (ANX), and cell death protease activation (CDP). Assay conditions simulated bloodstream (pH 7.5) or phagolysosomal (pH 5.5) pH contexts. S. aureus strains were more susceptible to HDPs at pH 7.5 than at pH 5.5, and each HDP exerted a distinct effect signature. The impacts of ΔgraS and ΔΕL on HDP resistance were peptide and pH dependent. Both mutants exhibited defects in ANX response to hNP-1 or hBD-2 at pH 7.5, but only hNP-1 did so at pH 5.5. Both mutants exhibited hyper-PRM, -ANX, and -CDP responses to RP-1 at both pHs and hypo-ENR at pH 5.5. The actions correlated with ΔgraS or ΔΕL hypersusceptibility to hNP-1 or RP-1 (but not hBD-2) at pH 7.5 and to all study HDPs at pH 5.5. An exogenous EL mimic protected mutant strains from hNP-1 and hBD-2 but not RP-1, indicating that GraS and its EL play nonredundant roles in S. aureus survival responses to specific HDPs. These findings suggest that GraS mediates specific resistance countermeasures to HDPs in immune contexts that are highly relevant to S. aureus pathogenesis in humans.

Indexed as

Anti-Infective AgentsAntimicrobial Cationic PeptidesBacterial ProteinsDrug Resistance, BacterialHumansHydrogen-Ion ConcentrationMicrobial Sensitivity TestsMutant ProteinsMutationStaphylococcus aureusAnti-Infective AgentsAntimicrobial Cationic PeptidesBacterial ProteinsMutant Proteins

Identifiers

PMID26597988
PMCPMC4730570
OpenAlexW2177893376

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.